(Q33368170)

26 July 2017

title

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. (English)

1 reference

26 July 2017

2

0 references

author name string

Karin Janetzko

1

1 reference

26 July 2017

Harald Klüter

3

1 reference

26 July 2017

Daniel Kientz

4

1 reference

26 July 2017

Martine Michel

5

1 reference

26 July 2017

Photis Beris

6

1 reference

26 July 2017

Bruno Lioure

7

1 reference

26 July 2017

Jan Hastka

8

1 reference

26 July 2017

Stephane Marblie

9

1 reference

26 July 2017

Veronique Mayaudon

10

1 reference

26 July 2017

Lily Lin

11

1 reference

26 July 2017

Jin-Sying Lin

12

1 reference

26 July 2017

Maureen G Conlan

13

1 reference

26 July 2017

Jocelyne Flament

14

1 reference

26 July 2017

publication date

1 September 2005

1 reference

26 July 2017

1 reference

26 July 2017

volume

45

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

1443-1452

1 reference

Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Factors influencing 20-hour increments after platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

Refractoriness to platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.00550.X

10.1111/J.1537-2995.2005.00550.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference